Ilyang, Nutra to join forces in new drug R&D
Published: 2009-01-02 06:57:00
Updated: 2009-01-02 06:57:00
Ilyang Pharm and Nutra R&BT Inc., a local biopharmaceutical company, have agreed to join hands to develop new for treatment of arthritis, stroke and atopic disease, including antioxidants so that they can stay competitive with multinational drug manufacturers.
“The two companies said they woul...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
